Lupin Receives USFDA Approval for Modafinil Tablets to Treat Excessive Sleepiness
Pharmaceutical company Lupin has received approval from the US Food and Drug Administration (USFDA) to market Modafinil tablets in 100 mg and 200 mg strengths. The drug, bioequivalent to Provigil Tablets by Nuvo Pharmaceuticals, is used to treat excessive sleepiness linked to narcolepsy, obstructive sleep apnea, and shift work disorder. Modafinil tablets had estimated annual US sales of USD 70.7 million. Lupin operates 15 manufacturing facilities and is present in over 100 global markets.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (53/100). Lens Score 41/100.
Outlets measured: businessstandard, economictimes, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 4 Sept, 12:46 pm. Other outlets followed.